Revenue
$2.2B
▼ 6.3% YoY
Net Income
$732,000
▲ 100.6% YoY
EPS
$0.03
▲ 100.6% YoY
Cash
$308.0M
▼ 0.2% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Bonnell Brian Michael Chief Financial Officer | Sell | Sep 1, 2026 | 6.4K | $175.00 | $1.12M | Form 4 ↗ |
Bonnell Brian Michael Chief Financial Officer | Sell | Aug 31, 2026 | 1.7K | $171.05 | $293K | Form 4 ↗ |
Bonnell Brian Michael Chief Financial Officer | Sell | Aug 31, 2026 | 1.9K | $172.12 | $329K | Form 4 ↗ |
Bonnell Brian Michael Chief Financial Officer | Sell | Aug 31, 2026 | 4.6K | $173.44 | $792K | Form 4 ↗ |
Bonnell Brian Michael Chief Financial Officer | Sell | Aug 31, 2026 | 1.1K | $173.91 | $194K | Form 4 ↗ |
Woolson Daniel VP, GM-Infusion Capital | Sell | Aug 13, 2026 | 5.4K | $181.33 | $982K | Form 4 ↗ |
Sousa Ben Chief Information Officer | Sell | Aug 12, 2026 | 2.3K | $178.32 | $401K | Form 4 ↗ |
Voigtlander Christian B. Chief Operating Officer | Sell | Aug 11, 2026 | 8.9K | $182.93 | $1.63M | Form 4 ↗ |
FINNEY ELISHA W Director | Sell | Aug 11, 2026 | 378 | $182.48 | $69K | Form 4 ↗ |